Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 235,889,642 papers from all fields of science
Search
Sign In
Create Free Account
CancerVax
Known as:
C-VAX
CancerVax is an allogenic polyvalent vaccine composed of irradiated but viable cells from three melanoma cell lines and Bacille Calmette-Guerin (BCG…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
polyvalent melanoma cell vaccine
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Reverse mergers attract top-tier biotechs in sluggish IPO market
S. Lawrence
Nature Biotechnology
2006
Corpus ID: 9614752
Essentially the acquisition of a public company shell by a privately-held company in order access public capital, the reverse…
Expand
2005
2005
Expediting Oncology Drug Approvals: The Public Backlash Against the FDA and Opportunities to Reform
Andrew J. Sung
2005
Corpus ID: 74628187
The FDA has made great strides over the past twenty years in loosening drug approval regulations to speed important, life-saving…
Expand
2005
2005
Somatic gene mutations predict outcome of patients receiving adjuvant active specific immunotherapy after resection of stage IV melanoma
R. Essner
,
Jonathan H. Lee
,
H. Itakura
,
Y. Huynh
,
T. Zogakis
,
D. Morton
2005
Corpus ID: 78339817
7522 Background: Cyoreductive surgery plus adjuvant active specific immunotherapy can improve prognosis in stage IV melanoma, if…
Expand
2003
2003
The Nature Biotechnology 2003 New Year Quiz
J. Alper
,
A. Bouchie
,
A. Marshall
,
Meeghan Sinclair
Nature Biotechnology
2003
Corpus ID: 10447067
9. Your roots are showing. Find the common corporate prefix. (a) ...-dex (Oxford, UK); ...-ron (Alameda, CA); and ...-va…
Expand
2002
2002
CancerVax Corporation temporarily halts enrolment in phase III melanoma trials
2002
Corpus ID: 195161078